Susan Lisa | Vice President of Investor Relations |
Michael Mahoney | Chairman and Chief Executive Officer |
Daniel Brennan | Executive Vice President and Chief Financial Officer |
Ian Meredith | Global Chief Medical Officer and Executive Vice President |
Kenneth Stein | SVP and Chief Medical Officer for Rhythm Management and Global Health Policy |
Robert Hopkins | Bank of America |
David Lewis | Morgan Stanley |
Rick Wise | Stifel Nicolaus |
Jason Mills | Canaccord Genuity |
Larry Biegelsen | Wells Fargo |
Vijay Kumar | Evercore ISI |
Matthew Taylor | UBS |
Chris Pasquale | Guggenheim |
Daniel Catenacci | SVB Leerink |
Matthew O'Brian | Piper Jaffray |
Ladies and gentlemen, thank you for standing by and welcome to the Boston Scientific Q1 2019 Earnings Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will be given at that time. [Operator Instructions] As a reminder, today’s call is being recorded. I would now like to turn the call over to your host, Susan Lisa.